Breast imaging is a diagnostic test that involves imaging of breasts for the detection of cancerous cells. The use of radiological images and medical technology aids in the detection of numerous different forms of breast cancer. Breast ultrasound, mammography, magnetic resonance imaging, and nuclear imaging are some of the technologies that are employed for breast imaging.
Breast imaging market is predicted to show significant growth in market size owing to various driving forces. There have been rising cases of breast cancer that are very difficult to diagnose in the early stages due to concealed symptoms. Breast cancer is diagnosed during later stages due to a lack of knowledge and awareness, leading to a higher mortality rate. According to World Health Organization, nearly 2.3 million women were diagnosed with breast cancer and about 0.6 million deaths, making it one of the most prevalent diseases in the global. As a result, the breast imaging market has been experiencing considerable growth over the past few years due to an increase in the use of various breast imaging techniques for the early detection of cancerous cells. Furthermore, In the upcoming years, it is expected that technological advancements in imaging techniques shall completely transform this market. Various approaches, such as combining imaging techniques like CT scans, MRIs, PET scans, and others, have been used to generate images with higher quality and more accuracy. Due to the increasing number of breast cancer cases, various organizations at the global level have come forward to raise awareness and arrange campaigns. For instance, every year, a National Mammography Program is organized by the National Breast Cancer Foundation, Inc. in the U.S., which provides free diagnosis for early detection and treatment of breast cancer. Therefore, it is likely that the market will expand rapidly as a result of the cited factors.
Although the breast imaging market is anticipated to grow in the forecast period, there might be some challenges this market will have to face. The high cost of using newer diagnostic techniques is one of the prime challenges. In addition, emerging economies cannot access the newer technologies required for screening. The market may not be able to expand as a result. The only method for diagnosing breast cancer is through technology, yet radiation exposure may be hazardous to the patient. It may be associated with certain side effects during the procedure. This, as well as the lack of knowledge, could hamper the expansion of the market.
Constant research and development may provide lucrative opportunities for players to increase their market share in the breast imaging market. Due to the increase in research in this market, ample growth opportunities may be available for the market players. Also, government agencies all around the global are interested in increasing the expenditure of this market. The demand for advanced technologies in the healthcare industry is on the rise, which has significantly increased the size of this market and thus serves as an opportunity for boosting the market size.
Recent developments to flourish in the market In 2022, a novel imaging device called NearWave Imager has been designed by researchers at the University of Notre Dame. This device is particularly used for a noninvasive type of breast imaging. This is anticipated to improve the screening technique with minimal side effects. Also, In May 2022, Barcelona Supercomputing Center coordinated a new European project; Quantitative Ultrasound Stochastic Tomography. This project has specifically been developed to replace the traditionally used X-ray based techniques such as mammograms. It is based on the mechanism of ultrasound and supercomputing that may supplement the currently available imaging techniques. Previously, In October 2021, a medical imaging company called Delphinus Medical Technologies revealed that the SoftVue 3D entire breast ultrasound tomography system has received premarket approval from the U.S. FDA. This system can be used for breast cancer screening providing much better results.
Segment Overview: By technology: Ionizing and nonIonizing segments make up the breast imaging market. In the approaching years, the ionizing market is projected to have the largest market share. This market segment has previously dominated market revenue, therefore going forward; it will likely continue to expand. This technology is in higher demand, which has drawn a variety of investors. Other than this, the introduction of newer ionization technologies has also contributed vastly to the growth of this segment. The market segment for nonionizing breast imaging is anticipated to experience the highest CAGR growth over the forecast period. This can be explained by the benefits nonionizing imaging technologies have over ionizing breast imaging technologies. Increased anatomical detail generation, excellent sensitivity to tiny breast lesions, and reduced false positives are a few of these benefits.
By modality: The breast imaging market is classified into, MRI, full-field digital mammography, ultrasound, positron emission mammography, and others. Breast MRI is a diagnostic exam that includes a powerful magnet, radio waves, and a computer to create precise pictures of the body's organs and structures. Positron emission mammography is a nuclear type of imaging technique used for the detection of cancerous cells in the breast. It makes use of injected positron-emitting isotope and a scanner to locate breast tumors.
By end-use: On basis of end-use, the breast imaging market is classified as hospitals, breast care centers, diagnosis imaging centers, and others. Out of this, the hospital segment is expected to show the highest growth in the forecast period. The main drivers of hospitals' dominance include significant investments in the development of healthcare infrastructure, rising purchasing power, the availability of operating and diagnostic rooms with modern equipment, and better health insurance for hospital-based healthcare services.
Competitive analysis and profiles of the major players in the breast imaging market, such as Aurora Imaging Company, Dilon Technologies, Fujifilm Holdings, Gamma, GE Healthcare, HologicInc., Philips healthcare, Siemens AG, Sonocine, and Toshiba Corporation are provided in this report.
Key Market Segments
- By Technology
- By Modality
- MRI
- Full-Field Digital Mammography
- Ultrasound
- Positron Emission Mammography
- Others
- By End Use
- Hospitals
- Breast Care Centers
- Diagnosis Imaging Centers
- Others
- By Region
- North America
- Europe
- France
- Germany
- Italy
- Spain
- UK
- Russia
- Rest of Europe
- Asia-Pacific
- China
- Japan
- India
- South Korea
- Australia
- Thailand
- Malaysia
- Indonesia
- Rest of Asia-Pacific
- LAMEA
- Brazil
- South Africa
- Saudi Arabia
- UAE
- Argentina
- Rest of LAMEA
Key Market Players
- Siemens AG
- philips healthcare
- Aurora Imaging Company
- Sonocine
- Gamma
- GE Healthcare
- Fujifilm Holdings
- Toshiba Corporation
- Hologic, Inc.
- Dilon Technologies